Emerging viruses and current strategies for vaccine intervention

Vaccinia-based vaccines to biothreat and emerging viruses

(2018) Les P. Nagata et al.   Biotechnology & Genetic Engineering Reviews

Use of a Scalable Replicon-Particle Vaccine to Protect Against Lethal Lassa Virus Infection in the Guinea Pig Model

(2018) Markus H Kainulainen et al.   JOURNAL OF INFECTIOUS DISEASES

Understanding orthopoxvirus host range and evolution: from the enigmatic to the usual suspects

(2018) Mary G Reynolds et al.   Current Opinion in Virology

An overview of the immunogenicity and effectiveness of current human rabies vaccines administered by intradermal route

(2018) Martine Denis et al.   VACCINE

Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology

(2017) Sarah C. Gilbert et al.   VACCINE

Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein

(2017) Benson Y.H. Cheng et al.   VIROLOGY

A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever

(2017) Kathleen A. Cashman et al.   Human Vaccines & Immunotherapeutics

After Ebola in West Africa — Unpredictable Risks, Preventable Epidemics

(2016)   NEW ENGLAND JOURNAL OF MEDICINE

Eradicating infectious disease using weakly transmissible vaccines

(2016) Scott L. Nuismer et al.   PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment

(2016) David K. Clarke et al.   VACCINE

Serological and Virological Evidence of Crimean-Congo Haemorrhagic Fever Virus Circulation in the Human Population of Borno State, Northeastern Nigeria

(2016) David N. Bukbuk et al.   PLoS Neglected Tropical Diseases

Formulation and stabilization of recombinant protein based virus-like particle vaccines

(2015) Nishant K. Jain et al.   ADVANCED DRUG DELIVERY REVIEWS

Self-disseminating vaccines for emerging infectious diseases

(2015) Aisling A. Murphy et al.   Expert Review of Vaccines

Development of Live-Attenuated Arenavirus Vaccines Based on Codon Deoptimization

(2015) Benson Yee Hin Cheng et al.   JOURNAL OF VIROLOGY

A cytomegalovirus-based vaccine provides long-lasting protection against lethal Ebola virus challenge after a single dose

(2015) Yoshimi Tsuda et al.   VACCINE

A bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: Application to emerging infectious diseases

(2015) Patricio Oyarzun et al.   VACCINE

The Evolution of Poxvirus Vaccines

(2015) Lucas Sánchez-Sampedro et al.   Viruses-Basel

Spillover and pandemic properties of zoonotic viruses with high host plasticity

(2015) Christine Kreuder Johnson et al.   Scientific Reports

Environmental Risk Assessment of Clinical Trials Involving Modified Vaccinia Virus Ankara (MVA)-Based Vectors

(2014) Martine Goossens et al.   CURRENT GENE THERAPY

Self-replicating alphavirus RNA vaccines

(2014) Karl Ljungberg et al.   Expert Review of Vaccines

A Novel Vaccine against Crimean-Congo Haemorrhagic Fever Protects 100% of Animals against Lethal Challenge in a Mouse Model

(2014) Karen R. Buttigieg et al.   PLoS One

The yellow fever 17D virus as a platform for new live attenuated vaccines

(2014) Myrna C Bonaldo et al.   Human Vaccines & Immunotherapeutics

Pre-existing immunity against Ad vectors

(2014) Hugues Fausther-Bovendo et al.   Human Vaccines & Immunotherapeutics

Zoonosis emergence linked to agricultural intensification and environmental change

(2013) B. A. Jones et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A global regulatory science agenda for vaccines

(2013) Lindsay Elmgren et al.   VACCINE

IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice

(2013) Shannan L. Rossi et al.   VIROLOGY

Single-Dose Immunization with Virus Replicon Particles Confers Rapid Robust Protection against Rift Valley Fever Virus Challenge

(2012) Kimberly A. Dodd et al.   JOURNAL OF VIROLOGY

Ecology of zoonoses: natural and unnatural histories

(2012) William B Karesh et al.   LANCET

A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity

(2012) Matthew D. J. Dicks et al.   PLoS One

Novel approaches to develop Rift Valley fever vaccines

(2012) Sabarish V. Indran et al.   Frontiers in Cellular and Infection Microbiology

Viral vectors as vaccine platforms: deployment in sight

(2011) Christine S Rollier et al.   CURRENT OPINION IN IMMUNOLOGY

A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial

(2011) Julie E. Ledgerwood et al.   JOURNAL OF INFECTIOUS DISEASES

Creation of a Recombinant Rift Valley Fever Virus with a Two-Segmented Genome

(2011) B. Brennan et al.   JOURNAL OF VIROLOGY

A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR−/− mice upon lethal virus challenge

(2011) Hani Boshra et al.   VACCINE

From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine

(2011) Bruno Guy et al.   VACCINE

Immunogenicity and protective efficacy of a vaxfectin-adjuvanted tetravalent dengue DNA vaccine

(2011) Kevin R. Porter et al.   VACCINE

HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX® B/E

(2011) Robert Paris et al.   VACCINE

Viruses—from pathogens to vaccine carriers

(2011) Juliana C Small et al.   Current Opinion in Virology

A DNA Vaccine against Chikungunya Virus Is Protective in Mice and Induces Neutralizing Antibodies in Mice and Nonhuman Primates

(2011) Karthik Mallilankaraman et al.   PLoS Neglected Tropical Diseases

Virus-Like Particles as Particulate Vaccines

(2010) Luigi Buonaguro et al.   CURRENT HIV RESEARCH

Virus-like particles in vaccine development

(2010) António Roldão et al.   Expert Review of Vaccines

Immunologic Basis of Vaccine Vectors

(2010) Margaret A. Liu   IMMUNITY

Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses

(2010) Danylo Sirskyj et al.   IMMUNOLOGY AND CELL BIOLOGY

Long-Term Thermostabilization of Live Poxviral and Adenoviral Vaccine Vectors at Supraphysiological Temperatures in Carbohydrate Glass

(2010) R. Alcock et al.   Science Translational Medicine

Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs

(2010) Xiaohong Jiang et al.   VACCINE

Replication-Deficient Ebolavirus as a Vaccine Candidate

(2009) P. Halfmann et al.   JOURNAL OF VIROLOGY

Bats and Emerging Zoonoses: Henipaviruses and SARS

(2009) H. E. Field   Zoonoses and Public Health

Cross-Species Virus Transmission and the Emergence of New Epidemic Diseases

(2008) C. R. Parrish et al.   MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS

Global trends in emerging infectious diseases

(2008) Kate E. Jones et al.   NATURE

Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates

(2008) Igor S. Lukashevich et al.   VACCINE

IRES-dependent replication of Venezuelan equine encephalitis virus makes it highly attenuated and incapable of replicating in mosquito cells

(2008) Eugenia Volkova et al.   VIROLOGY